Article Sidebar

PDF
Date Published: 04/09/2023
Abstract Views: 148
Views PDF: 57
DOI: https://doi.org/10.47972/vjcts.v43i.1038
Issue
Vol. 43: SỐ ĐẶC BIỆT CỦA HỘI TIM MẠCH THÀNH PHỐ HÀ NỘI
Section
Research Article
How to Cite
Vu, T. T., Pham, N. H., & Nguyen, T. B. Y. (2023). Assess the pulmonary arterial pressure in patients with group 1 pulmonary arterial hypertension by echocardiography. The Vietnam Journal of Cardiovascular and Thoracic Surgery, 43, 266 - 271. https://doi.org/10.47972/vjcts.v43i.1038

Assess the pulmonary arterial pressure in patients with group 1 pulmonary arterial hypertension by echocardiography

Thi Trang Vu, Nhu Hung Pham1,, Thi Bach Yen Nguyen
1 Hanoi Heart Hospital

Main Article Content

Abstract

Objective: We assess the right ventricular in patients with group 1 pulmonary arterial hypertension by echocardiography.


Method and Results: 45 patients with group 1 pulmonary arterial hypertension was measured the right ventricular by echocardiography between September 2021 and October 2022. Right ventricular diameter and Right ventricular area in patients with idiopathic pulmonary arterial hypertension were not significantly different in patients with secondary pulmonary arterial hypertension (35.7 ± 10.1 mm versus 30.8 ± 9 mm; p=0,12)  và (24.1 ± 11.6 cm2 versus 19.7 ± 7 cm2; p=0,12). However, right ventricular function in patients with idiopathic pulmonary arterial hypertension were significantly lower than in patients with secondary pulmonary arterial hypertension via %FAC (28.3 ± 8.5 versus 38.8 ± 8.3; p<0,001), TAPSE (14.2 ± 3.1 mm versus 19.4 ± 3.5 mm; p<0,001), S’tricuspid (9.6 ± 2.2 cm/s versus 11.7 ± 1.9;p=0,002).[1]


Conclusion: Right ventricular function in patients with idiopathic pulmonary arterial hypertension was significantly lower than in patients with secondary arterial pulmonary hypertension.

Article Details

Keywords

Group 1 pulmonary arterial hypertension, pulmonary arterial pressure

References

1. Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG). European Heart Journal. 2022;43(38):3618-3731. doi:10.1093/ eurheartj/ehac237.
2. Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). European Respiratory Journal. 2015;46(4):903-975. doi:10.1183/13993003.01032-2015
3. Masson E. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. EM-Consulte. Accessed November 7, 2022. https://www.em-consulte.com/article/949199/recommendations-for-cardiac-chamber-quantification
4. Rich JD, Thenappan T, Freed B, et al. QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension. Int J Cardiol. 2013;167(3):669-676. doi:10.1016 /j.ijcard.2012. 03.071.
5. Moceri P, Bouvier P, Baudouy D, et al. Cardiac remodelling amongst adults with various aetiologies of pulmonary arterial hypertension including Eisenmenger syndrome-implications on survival and the role of right ventricular transverse strain. European Heart Journal - Cardiovascular Imaging. 2017;18(11):1262-1270. doi:10.1093 /ehjci/jew277.